12 results for author:"Sainty D." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| HLA-DR and B7-2 (CD86) monocyte expressions after major cancer surgery: profile in sepsis. Mokart D., Textoris J., Chow-Chine L., Brun J.P., Sannini A., Turrini O., Blache J.L., Arnoulet C., Sainty D., Leone M. Minerva Anestesiol 77:522-527(2011) · Mapped (5) |
| The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome. Prebet T., Lhoumeau A.-C., Arnoulet C., Aulas A., Marchetto S., Audebert S., Puppo F., Chabannon C., Sainty D., Santoni M.-J. et al. Blood 116:2315-2323(2010) · UniProtKB (1) |
| Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Gelsi-Boyer V., Trouplin V., Adelaide J., Bonansea J., Cervera N., Carbuccia N., Lagarde A., Prebet T., Nezri M., Sainty D. et al. Br. J. Haematol. 145:788-800(2009) · UniProtKB (1) · Mapped (4) |
| Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. Gelsi-Boyer V., Trouplin V., Adelaide J., Aceto N., Remy V., Pinson S., Houdayer C., Arnoulet C., Sainty D., Bentires-Alj M. et al. |
| Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogenetique hematologique. Gervais C., Murati A., Helias C., Struski S., Eischen A., Lippert E., Tigaud I., Penther D., Bastard C., Mugneret F. et al. Leukemia 22:1567-1575(2008) · Mapped (3) |
| A fifteen-year cytogenetic remission following interferon treatment in a patient with an indolent ETV6-ABL positive myeloproliferative syndrome. Mozziconacci M.J., Sainty D., Chabannon C. Am. J. Hematol. 82:688-689(2007) · Mapped (17) |
| New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias. Murati A., Adelaide J., Quilichini B., Remy V., Sainty D., Stoppa A.M., Bernard P., Olschwang S., Birnbaum D., Chaffanet M. et al. Haematologica 92:262-263(2007) · Mapped (8) |
| t(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera. Murati A., Adelaide J., Gelsi-Boyer V., Etienne A., Remy V., Fezoui H., Sainty D., Xerri L., Vey N., Olschwang S. et al. Leukemia 20:1175-1178(2006) · Mapped (12) |
| FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice. Guasch G., Delaval B., Arnoulet C., Xie M.J., Xerri L., Sainty D., Birnbaum D., Pebusque M.J. Blood 103:309-312(2004) · Mapped (2) |
| Induction of T helper type 2 immunity by a point mutation in the LAT adaptor. Aguado E., Richelme S., Nunez-Cruz S., Miazek A., Mura A.M., Richelme M., Guo X.J., Sainty D., He H.T., Malissen B. et al. |
| A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. Costello R.T., Sivori S., Mallet F., Sainty D., Arnoulet C., Reviron D., Gastaut J.A., Moretta A., Olive D. Leukemia 16:855-860(2002) · Mapped (4) |
| Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Rosnet O., Buhring H.J., Marchetto S., Rappold I., Lavagna C., Sainty D., Arnoulet C., Chabannon C., Kanz L., Hannum C. et al. Leukemia 10:238-248(1996) · UniProtKB (1) |